The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Bellerophon Therapeutics, Inc(PINK:BLPH) 
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hyper...
Website: http://www.bellerophon.com
Founded: 2009
Full Time Employees: 18
Sector: Healthcare
Industry: Biotechnology
Bellerophon Therapeutics Op Cashflow Per Share ttm
Bellerophon Therapeutics Free Cashflow Per Share ttm
Bellerophon Therapeutics Cash Per Share ttm
Bellerophon Therapeutics P/S ratio ttm
Bellerophon Therapeutics (GAAP) P/E ratio ttm
Bellerophon Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.